GENE ONLINE|News &
Opinion
Blog

CRISPR Therapeutics
Groundbreaking CRISPR/Cas9-based Genome Editing Therapy Secured the Second FDA Approval
2024-01-18
FDA Approves A CRISPR-Based Therapy for Sickle Cell Disease
2023-12-12
GeneOnline’s Weekly News Highlights: Nov 13-Nov 17
2023-11-20
Canadian Regulators Give Go-Ahead for Diabetes Trial Using CRISPR, ViaCyte’s Gene-Edited Stem Cell-Derived Therapy
2021-11-16
Setting its Sights on Neurological Disorders, CRISPR Therapeutics Turns to an AAV Startup That Just Emerged Out of Stealth
2021-06-16
Vertex to Reap Majority Profits from Gene Editing Deal with CRISPR Therapeutics
2021-04-21
10 Top Gene Therapy Companies in 2021
2021-03-26
CRISPR Therapeutics Scores Prestigious Grant for Advancing Gene Therapies for HIV
2020-12-16
CRISPR Gene-Edited Therapy CTX001 Raises Hopes for Sickle Cell Disease and β-Thalassemia Cures
2020-12-07
CRISPR Therapeutics’ CAR-T Cell Therapy Registers Mixed Results in Cancer Trial
2020-10-23
CRISPR, Vertex’s Gene Editing Based Therapy, CTX001 Prospers in Hemoglobinopathy Trials
2020-06-18
GeneOnline’s Top Ten Headlines of the Year
2019-12-30
R&D
Gene Editing Companies to Exchange Patented Tech to Develop Cancer Therapies
2019-10-28
LATEST
Kaiser’s Data Breach: 13.4 Million Affected in Healthcare Conglomerates Privacy Crisis
2024-04-26
Mechanisms of Allograft Rejection: Insights from Behind the Scenes
2024-04-25
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
Ochre Bio Announces Partnership with Boehringer Ingelheim to Develop Novel Regenerative Treatments for Patients with Advanced Liver Disease
2024-04-22
Earth Day Awareness: Hospitals Embrace Sustainability Efforts
2024-04-22
WHO Raises Alarm: Bird Flu Threat to Humans an ‘Enormous Concern’
2024-04-19
EVENT
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115
Scroll to Top